FindTrial
Sign In

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2012-002768-28-FR
Enrollment
Unknown
Registered
2012-09-12
Start date
2012-09-12
Completion date
Unknown
Last updated
2016-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: MODOPAR Pharmaceutical Form: Tablet for oral suspension INN or Proposed INN: LEVODOPA CAS Number: 59-92-7 Concentration unit: mg milligram(s) Concentration type: equal Concentration number

Sponsors

CHU Clermont-Ferrand
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 20 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 20

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

France

Contacts

Public ContactPatrick Lacarin

DRCI

placarin@chu-clermontferrand.fr+33473 751 195

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026